TABLE 1.
Isolate | Country or strain | Cluster | % Survival | No. of pXO1 (rpXO1) | No. of pXO2 (rpXO2) |
---|---|---|---|---|---|
Model isolate set | |||||
1 | China | A3b | 0 | 185 (30.9) | 9 (1.5) |
2 | Australia | A3a | 0 | 121 (20.2) | 32 (5.4) |
3 | Namibia | A3a | 19 | 242 (40.3) | 5 (0.9) |
4 | Ames | A3b | 38 | 65 (10.8) | 2 (0.3) |
5 | Germany | A3a | 25 | 113 (18.9) | 5 (0.9) |
6 | Turkey | A3a | 31 | 131 (21.8) | 11 (1.8) |
7 | France | B2 | 31 | 243 (40.5) | 4 (0.6) |
8 | Turkey | A1b | 38 | 236 (39.4) | 27 (4.5) |
9 | Pakistan | A2 | 38 | 120 (20.0) | 1 (0.2) |
10 | South Africa | B1 | 44 | 66 (11.0) | 2 (0.4) |
11 | Zambia | A3a | 44 | 242 (40.4) | 15 (2.5) |
12 | Turkey | A1b | 44 | 172 (28.7) | 6 (1.0) |
13 | United States | A3a | 44 | 109 (18.1) | 4 (0.7) |
14 | South Africa | A3b | 50 | 212 (35.3) | 16 (2.6) |
15 | Argentina | A3a | 50 | 104 (17.4) | 7 (1.2) |
16 | Mozambique | B1 | 75 | 95 (15.9) | 1 (0.2) |
17 | Canada | A1a | 69 | 24 (40.5) | 18 (3.0) |
18 | United States | A1a | 69 | 128 (21.4) | 5 (0.8) |
19 | Pakistan | A4 | 75 | 191 (31.9) | 14 (2.3) |
20 | Vollum | A4 | 94 | 69 (11.5) | 10 (1.6) |
Test isolate set | |||||
A | Indonesia | A4 | 13 | 44.4 (7.4) | 4 (0.6) |
B | South Korea | A3a | 19 | 62 (10.4) | 3 (0.5) |
C | United States | A3a | 19 | 89 (14.8) | 3 (0.5) |
D | South Africa | A4 | 25 | 94 (15.6) | 11 (1.9) |
E | India | A3a | 25 | 33 (5.5) | 2 (0.4) |
F | United States | A3b | 31 | 44 (7.3) | 2 (0.4) |
G | Mozambique | B1 | 44 | 86 (14.4) | 10 (1.6) |
H | Norway | B1 | 44 | 218 (36.3) | 1 (0.2) |
I | Croatia | B1 | 44 | 49 (8.2) | 3 (0.5) |
J | Canada | A1a | 50 | 83 (13.9) | 5 (0.9) |
K | United States | A1a | 50 | 65 (10.8) | 4 (0.7) |
L | United States | A1a | 56 | 115 (19.2) | 9 (1.5) |